Computational approaches for predicting key transcription factors in targeted cell reprogramming (Review)

Area of Science:

• Cell biology
• Bioinformatics
• Regenerative medicine

Background:

• Specific cell types are crucial for research and regenerative medicine but often difficult to obtain in sufficient quantities.
• Direct cell reprogramming, including transdifferentiation and induced pluripotent stem cell (iPSC) re-induction, offers a solution by generating desired cell types.
• Identifying the correct cocktail of transcription factors (TFs) is essential for successful cell reprogramming but remains a significant challenge.

Purpose of the Study:

• To review and compare four computational approaches for identifying transcription factors (TFs) for direct cell reprogramming.
• To provide a simplified framework for understanding the computational complexity of TF identification methods.
• To offer insights and tools for researchers working on direct cell conversions.

Main Methods:

• The study reviews four existing computational approaches for TF identification.
• A simplified conceptual framework is presented, involving defining target/non-target cells, estimating candidate TFs, and filtering candidates.
• The framework's validity was tested using cardiomyocyte differentiation and applied to corneal endothelial cell differentiation.

Main Results:

• The review simplifies the complex computational methods for TF identification into three core steps.
• The simplified approach was validated using a known cell differentiation process (cardiomyocytes).
• The methods were applied to an understudied cell type (corneal endothelial cells), yielding potentially valuable results.

Conclusions:

• Computational approaches can aid in identifying necessary transcription factors (TFs) for direct cell reprogramming.
• A simplified understanding of TF identification methods can facilitate their application in various cell types.
• The study provides practical insights and resources to support direct cell conversion efforts in regenerative medicine and research.